REFERENCIAS BIBLIOGRÁFICAS

1. P.N. Ravindran, K. Nirmal Babu, K. Sivaraman, “Turmeric: the genus Curcuma, ” CRC Press, Boca Raton, FL, 2007, pp. 130.
2. EMA. Committee on Herbal Medicinal Products (HMPC). Assessment report on Curcuma longa L., rizoma. EMA/HMPC/329745/2017. Disponible en https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-curcuma-longa-l-rhizoma-revision-1_en.pdf (última consulta octubre 2019)
3. Schneider W. Lexikon zur Arzneimittelgeschichte-Pflanzliche Drogen. Govi-Verlag GmbHPharmazeutischer Verlag, Frankfurt 1974
4. Sindhu S, Chempakam B, Leela NK, Suseela Bhai R. Chemoprevention by essential oil of turmeric leaves (Curcuma longa L.) on the growth of Aspergillus flavus and aflatoxin production. Food Chem Toxicol. 2011; 49 (5): 1188-92. doi: 10.1016/j.fct.2011.02.014.
5. Grynkiewicz G1, Ślifirski P. Curcumin and curcuminoids in quest for medicinal status. Acta Biochim Pol. 2012;59(2):201-12
6. Witkin JM1, Li X. Curcumin, an active constiuent of the ancient medicinal herb Curcuma longa L.: some uses and the establishment and biological basis of medical efficacy. CNS Neurol Disord Drug Targets. 2013 Jun;12(4):487-97.
7. Rasyid A1, Rahman AR, Jaalam K, Lelo A. Effect of different curcumin dosages on human gall bladder. Asia Pac J Clin Nutr. 2002;11(4):314-8.
8. Carretero Accame ME. Plantas Medicinales en el Tratamiento de Alteraciones Hepatobiliares (V): Cúrcumas. Portalfarma. Documento online: https://botplusweb.portalfarma.com/documentos/2012/2/9/50910.pdf (última consulta octubre 2019)
9. Prucksunand C, Indrasukhsri B, Leethochawalit M, Hungspreugs K. Phase II clinical trial on effect of the long turmeric (Curcuma longa Linn) on healing of peptic ulcer. Southeast Asian J Trop Med Public Health 2001; 32(1): 208-215
10. Di Mario F1, Cavallaro LG, Nouvenne A, Stefani N, Cavestro GM, et al. A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? Helicobacter. 2007 Jun;12(3):238-43.
11. European Medicines Agency (EMA) – Committee on Herbal Medicinal Products (HMPC). Final European Union herbal monograph on Curcuma longa L., rhizoma – Revision 1. London: EMA. Doc. Ref.: EMA/HMPC/329755/2017. Publicación: 24/1/2019.
12. Belcaro G1, Cesarone MR, Dugall M, Pellegrini L, Ledda A, et al. Product-evaluation registry of Meriva®, a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritis. Panminerva Med. 2010 Jun;52(2 Suppl 1):55-62.
13. Daily JW, Yang M, Park S. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Med Food. 2016; 19 (8): 717-29.
14. Henrotin Y1, Gharbi M, Dierckxsens Y, Priem F, Marty M, Seidel L, et al. Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial. BMC Complement Altern Med. 2014 May 17;14:159. doi: 10.1186/1472-6882-14-159.
15. McCann MJ, Johnston S, Reilly K, et al. The effect of turmeric (Curcuma longa) extract on the functionality of the solute carrier protein 22 A4 (SLC22A4) and interleukin-10 (IL-10) variants associated with inflammatory bowel disease. Nutrients. 2014;6(10):4178-4190. Published 2014 Oct 13. doi:10.3390/nu6104178
16. Taylor RA, Leonard MC. Curcumin for inflammatory bowel disease: a review of human studies. Altern Med Rev. 2011; 16 (2): 152-6.
17. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003 Jan-Feb;23(1A):363-98. PMID: 12680238.
18. Serkan Sertel, Tolga Eichhorn, Judith Bauer, Kai Hock, Peter K. Plinkert, Thomas Efferth, Pharmacogenomic determination of genes associated with sensitivity or resistance of tumor cells to curcumin and curcumin derivatives, The Journal of Nutritional Biochemistry, Volume 23, Issue 8, 2012, Pages 875-884
19. da Costa IM, Freire MAM, de Paiva Cavalcanti JRL, de Araújo DP, Norrara B, et al. Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimer’s Disease: A Systematic Review. Curr Neuropharmacol. 2019;17(5):406-421. doi: 10.2174/0929867325666180117112610.
20. Ng TP1, Chiam PC, Lee T, Chua HC, Lim L, Kua EH. Curry consumption and cognitive function in the elderly. Am J Epidemiol. 2006 Nov 1;164(9):898-906.
21. Kalani et al. Metab Brain Dis. Author manuscript; available in PMC 2016 Apr 1.Published in final edited form as: Metab Brain Dis. 2015 Apr; 30(2): 427–435. Published online 2014 May 1. doi: 10.1007/s11011-014-9537-0

Sobre la autora:

María José Alonso Osorio

  •  Licenciada en Farmacia por la Universidad de Barcelona.
  • Diplomada en Fitoterapia por la Universidad de Montpellier.
  • Especialista en Farmacia Galénica e Industrial.
  • Director Técnico y responsable de desarrollo de productos en Industria Farmacéutica (1972 a 1985).
  • Farmacéutica comunitaria (desde 1985 hasta 2004 como titular y copropietaria, desde 2010 como substituta a tiempo parcial).
  • Vocal de Plantas Medicinales y Homeopatía del Colegio de Farmacéuticos de Barcelona (desde 1997 hasta la actualidad).
  • Vocal de Alimentación del Colegio de Farmacéuticos de Barcelona (2011 – 2012).
  • Co-directora del Master Interuniversitario de Fitoterapia organizado por la Universidad Autónoma de Barcelona (Fundación Robert), Universidad de Barcelona (Facultad de Farmacia) y Colegio de Farmacéuticos de Barcelona (desde la primera edición 2003 hasta la actualidad: 6ª edición).
  • Vocal de la Junta de Gobierno de la Sociedad Española de Fitoterapia.
  • Miembro del Comité Científico de INFITO (Centro de Investigación sobre Fitoterapia).
  • Académica correspondiente de la Real Academia de Farmacia de Cataluña.